X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

WAPG and Astellas Announce Future Innovator Prize to Help Emerging Biotechs Accelerate Early Drug Discovery and Research Efforts

Content Team by Content Team
22nd October 2021
in Drug Development, News, Research & Development
WAPG and Astellas Announce Future Innovator Prize to Help Emerging Biotechs Accelerate Early Drug Discovery and Research Efforts

Life Science Newswire – Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc, and We are Pioneer Group (WAPG), the UK’s largest ecosystem provider for science and innovation businesses, announce a new collaborative sponsorship and first of its kind initiative to support early stage science ventures.

The “Future Innovator Prize” offers scientists and biotech start-ups one year of free accommodation at selected We are Pioneer Group locations and membership to the WAPG’s community of scientists, technologists and entrepreneurs; which is the largest in the UK. In addition, Future Innovator Prize winners will also receive unprecedented access to Astellas’ R&D capabilities, business leaders, mentors and global network of partner academic institutes and biotechnology companies.

The collaborative sponsorship between Astellas and WAPG is the first such offering in the UK, and a flagship initiative for the newly-founded WAPG following the acquisition of BioCity Group in April 2021.

“We are delighted to partner with Astellas to support promising early-stage science ventures,” said Ayokunmi Ajetunmobi, venture development manager at We are Pioneer Group. “The Future Innovator Prize creates a crucial link between innovation and industry that will enable the translation of research, into meaningful value for patients.”

“The UK market is extremely important to our continued expansion outside the US in our mission to become the Partner of Choice in the biopharmaceutical space by identifying emerging companies that can help us achieve and realize our VISION of turning innovative science into VALUE for patients,” said Maruyama, President, AVM. “With nine locations across the UK, we believe We are Pioneer Group are singularly positioned to allow start-ups to transform exciting ideas into real businesses that could benefit from our expertise in R&D.”

“With Astellas, we share the vision of supporting early-stage ventures and have witnessed the impact of a similar sponsorship with LabCentral in Boston,” agreed Ajetunmobi. “With the Future Innovator Prize, we believe we can create significant acceleration and growth opportunities for pioneering biotechs and unlock the current nascent potential of the UK science industry, enabling it to compete on a global level.”

Astellas and WAPG today issue an open call for the Future Innovator Prize. Applications are welcome from entrepreneurial scientists, life science and biotechnology start-ups that are developing pioneering scientific and technology platform that would be a game-changing approach in Astellas’ interest areas including Blindness & Regeneration, Mitochondria Biology, Genetic Regulation, Immuno-Oncology, Cell Therapy, and other areas.

Previous Post

Aptar Pharma and i2c Pharmaceutical Services Announce Partnership for Next Generation Propellant Dispersible Tablet pMDI Technology

Next Post

Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy Facility

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy Facility

Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy Facility

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In